Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Caitlyn Tompkins, PharmD
Advertisement
Articles by Caitlyn Tompkins, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
3
Patient-Reported Outcomes, Machine Learning May Predict Breast Cancer Recurrence Earlier
4
Psychedelics in Cluster Headaches Are Breaking the Pain Cycle
5